Complications associated with sentinel lymph node biopsy for melanoma
Sentinel lymph node (SLN) biopsy has become widely accepted as a method of staging the regional lymph nodes for patients with melanoma. Although it is often stated that SLN biopsy is a minimally invasive procedure associated with few complications, a paucity of data exists to specifically determine...
Gespeichert in:
| Veröffentlicht in: | Annals of surgical oncology 2003-07, Vol.10 (6), p.676-680 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 680 |
|---|---|
| container_issue | 6 |
| container_start_page | 676 |
| container_title | Annals of surgical oncology |
| container_volume | 10 |
| creator | Wrightson, William R Wong, Sandra L Edwards, Michael J Chao, Celia Reintgen, Douglas S Ross, Merrick I Noyes, R Dirk Viar, Vicki Cerrito, Patricia B McMasters, Kelly M |
| description | Sentinel lymph node (SLN) biopsy has become widely accepted as a method of staging the regional lymph nodes for patients with melanoma. Although it is often stated that SLN biopsy is a minimally invasive procedure associated with few complications, a paucity of data exists to specifically determine the morbidity associated with this procedure. This analysis was performed to evaluate the morbidity associated with SLN biopsy compared with completion lymph node dissection (CLND).
Patients were enrolled in the Sunbelt Melanoma Trial, a prospective multi-institutional study of SLN biopsy for melanoma. Patients underwent SLN biopsy and were prospectively followed up for the development of complications associated with this technique. Patients who had evidence of nodal metastasis in the SLN underwent CLND. Complications associated with SLN biopsy alone were compared with those associated with SLN biopsy plus CLND.
A total of 2120 patients were evaluated, with a median follow-up of 16 months. Overall, 96 (4.6%) of 2120 patients developed major or minor complications associated with SLN biopsy, whereas 103 (23.2%) of 444 patients experienced complications associated with SLN biopsy plus CLND. There were no deaths associated with either procedure.
SLN biopsy alone is associated with significantly less morbidity compared with SLN biopsy plus CLND. |
| doi_str_mv | 10.1245/ASO.2003.10.001 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73424428</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>931230241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-f860039c332715065865c96c23a9047f148aae2d477539eac7384803443f423d3</originalsourceid><addsrcrecordid>eNpdkE1LAzEQhoMoVqtnbxI8eNs2yeRrj6XUDyj0oJ6XNJulKbubdbOL9N-b0oLgaYbhmeGdB6EHSmaUcTFffGxmjBCYpQEh9ALdUAE841LTy9QTqbOcSTFBtzHuE6CAiGs0oUxDrgXcoNUyNF3trRl8aCM2MQbrzeBK_OOHHY6uHXzralwfmm6H21A6vPWhiwdchR43rjZtaMwduqpMHd39uU7R18vqc_mWrTev78vFOrMg5ZBVWqasuQVgigoihZbC5tIyMDnhqqJcG-NYyZUSkDtjFWiuCXAOFWdQwhQ9n-52ffgeXRyKxkfr6pTChTEWCjjjPD03RU__wH0Y-zZlKxhTkGKIIzQ_QbYPMfauKrreN6Y_FJQUR71F0lsc9R4HyV7aeDyfHbeNK__4s0_4BSo0c0w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227360058</pqid></control><display><type>article</type><title>Complications associated with sentinel lymph node biopsy for melanoma</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Wrightson, William R ; Wong, Sandra L ; Edwards, Michael J ; Chao, Celia ; Reintgen, Douglas S ; Ross, Merrick I ; Noyes, R Dirk ; Viar, Vicki ; Cerrito, Patricia B ; McMasters, Kelly M</creator><creatorcontrib>Wrightson, William R ; Wong, Sandra L ; Edwards, Michael J ; Chao, Celia ; Reintgen, Douglas S ; Ross, Merrick I ; Noyes, R Dirk ; Viar, Vicki ; Cerrito, Patricia B ; McMasters, Kelly M ; Sunbelt Melanoma Trial Study Group ; For the Sunbelt Melanoma Trial Study Group</creatorcontrib><description>Sentinel lymph node (SLN) biopsy has become widely accepted as a method of staging the regional lymph nodes for patients with melanoma. Although it is often stated that SLN biopsy is a minimally invasive procedure associated with few complications, a paucity of data exists to specifically determine the morbidity associated with this procedure. This analysis was performed to evaluate the morbidity associated with SLN biopsy compared with completion lymph node dissection (CLND).
Patients were enrolled in the Sunbelt Melanoma Trial, a prospective multi-institutional study of SLN biopsy for melanoma. Patients underwent SLN biopsy and were prospectively followed up for the development of complications associated with this technique. Patients who had evidence of nodal metastasis in the SLN underwent CLND. Complications associated with SLN biopsy alone were compared with those associated with SLN biopsy plus CLND.
A total of 2120 patients were evaluated, with a median follow-up of 16 months. Overall, 96 (4.6%) of 2120 patients developed major or minor complications associated with SLN biopsy, whereas 103 (23.2%) of 444 patients experienced complications associated with SLN biopsy plus CLND. There were no deaths associated with either procedure.
SLN biopsy alone is associated with significantly less morbidity compared with SLN biopsy plus CLND.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/ASO.2003.10.001</identifier><identifier>PMID: 12839853</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Adult ; Aged ; Female ; Humans ; Lymph Node Excision - adverse effects ; Male ; Melanoma - pathology ; Middle Aged ; Morbidity ; Postoperative Complications ; Sentinel Lymph Node Biopsy - adverse effects ; Skin Neoplasms - pathology</subject><ispartof>Annals of surgical oncology, 2003-07, Vol.10 (6), p.676-680</ispartof><rights>The Society of Surgical Oncology, Inc. 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-f860039c332715065865c96c23a9047f148aae2d477539eac7384803443f423d3</citedby><cites>FETCH-LOGICAL-c366t-f860039c332715065865c96c23a9047f148aae2d477539eac7384803443f423d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12839853$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wrightson, William R</creatorcontrib><creatorcontrib>Wong, Sandra L</creatorcontrib><creatorcontrib>Edwards, Michael J</creatorcontrib><creatorcontrib>Chao, Celia</creatorcontrib><creatorcontrib>Reintgen, Douglas S</creatorcontrib><creatorcontrib>Ross, Merrick I</creatorcontrib><creatorcontrib>Noyes, R Dirk</creatorcontrib><creatorcontrib>Viar, Vicki</creatorcontrib><creatorcontrib>Cerrito, Patricia B</creatorcontrib><creatorcontrib>McMasters, Kelly M</creatorcontrib><creatorcontrib>Sunbelt Melanoma Trial Study Group</creatorcontrib><creatorcontrib>For the Sunbelt Melanoma Trial Study Group</creatorcontrib><title>Complications associated with sentinel lymph node biopsy for melanoma</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><description>Sentinel lymph node (SLN) biopsy has become widely accepted as a method of staging the regional lymph nodes for patients with melanoma. Although it is often stated that SLN biopsy is a minimally invasive procedure associated with few complications, a paucity of data exists to specifically determine the morbidity associated with this procedure. This analysis was performed to evaluate the morbidity associated with SLN biopsy compared with completion lymph node dissection (CLND).
Patients were enrolled in the Sunbelt Melanoma Trial, a prospective multi-institutional study of SLN biopsy for melanoma. Patients underwent SLN biopsy and were prospectively followed up for the development of complications associated with this technique. Patients who had evidence of nodal metastasis in the SLN underwent CLND. Complications associated with SLN biopsy alone were compared with those associated with SLN biopsy plus CLND.
A total of 2120 patients were evaluated, with a median follow-up of 16 months. Overall, 96 (4.6%) of 2120 patients developed major or minor complications associated with SLN biopsy, whereas 103 (23.2%) of 444 patients experienced complications associated with SLN biopsy plus CLND. There were no deaths associated with either procedure.
SLN biopsy alone is associated with significantly less morbidity compared with SLN biopsy plus CLND.</description><subject>Adult</subject><subject>Aged</subject><subject>Female</subject><subject>Humans</subject><subject>Lymph Node Excision - adverse effects</subject><subject>Male</subject><subject>Melanoma - pathology</subject><subject>Middle Aged</subject><subject>Morbidity</subject><subject>Postoperative Complications</subject><subject>Sentinel Lymph Node Biopsy - adverse effects</subject><subject>Skin Neoplasms - pathology</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkE1LAzEQhoMoVqtnbxI8eNs2yeRrj6XUDyj0oJ6XNJulKbubdbOL9N-b0oLgaYbhmeGdB6EHSmaUcTFffGxmjBCYpQEh9ALdUAE841LTy9QTqbOcSTFBtzHuE6CAiGs0oUxDrgXcoNUyNF3trRl8aCM2MQbrzeBK_OOHHY6uHXzralwfmm6H21A6vPWhiwdchR43rjZtaMwduqpMHd39uU7R18vqc_mWrTev78vFOrMg5ZBVWqasuQVgigoihZbC5tIyMDnhqqJcG-NYyZUSkDtjFWiuCXAOFWdQwhQ9n-52ffgeXRyKxkfr6pTChTEWCjjjPD03RU__wH0Y-zZlKxhTkGKIIzQ_QbYPMfauKrreN6Y_FJQUR71F0lsc9R4HyV7aeDyfHbeNK__4s0_4BSo0c0w</recordid><startdate>20030701</startdate><enddate>20030701</enddate><creator>Wrightson, William R</creator><creator>Wong, Sandra L</creator><creator>Edwards, Michael J</creator><creator>Chao, Celia</creator><creator>Reintgen, Douglas S</creator><creator>Ross, Merrick I</creator><creator>Noyes, R Dirk</creator><creator>Viar, Vicki</creator><creator>Cerrito, Patricia B</creator><creator>McMasters, Kelly M</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20030701</creationdate><title>Complications associated with sentinel lymph node biopsy for melanoma</title><author>Wrightson, William R ; Wong, Sandra L ; Edwards, Michael J ; Chao, Celia ; Reintgen, Douglas S ; Ross, Merrick I ; Noyes, R Dirk ; Viar, Vicki ; Cerrito, Patricia B ; McMasters, Kelly M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-f860039c332715065865c96c23a9047f148aae2d477539eac7384803443f423d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Female</topic><topic>Humans</topic><topic>Lymph Node Excision - adverse effects</topic><topic>Male</topic><topic>Melanoma - pathology</topic><topic>Middle Aged</topic><topic>Morbidity</topic><topic>Postoperative Complications</topic><topic>Sentinel Lymph Node Biopsy - adverse effects</topic><topic>Skin Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wrightson, William R</creatorcontrib><creatorcontrib>Wong, Sandra L</creatorcontrib><creatorcontrib>Edwards, Michael J</creatorcontrib><creatorcontrib>Chao, Celia</creatorcontrib><creatorcontrib>Reintgen, Douglas S</creatorcontrib><creatorcontrib>Ross, Merrick I</creatorcontrib><creatorcontrib>Noyes, R Dirk</creatorcontrib><creatorcontrib>Viar, Vicki</creatorcontrib><creatorcontrib>Cerrito, Patricia B</creatorcontrib><creatorcontrib>McMasters, Kelly M</creatorcontrib><creatorcontrib>Sunbelt Melanoma Trial Study Group</creatorcontrib><creatorcontrib>For the Sunbelt Melanoma Trial Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wrightson, William R</au><au>Wong, Sandra L</au><au>Edwards, Michael J</au><au>Chao, Celia</au><au>Reintgen, Douglas S</au><au>Ross, Merrick I</au><au>Noyes, R Dirk</au><au>Viar, Vicki</au><au>Cerrito, Patricia B</au><au>McMasters, Kelly M</au><aucorp>Sunbelt Melanoma Trial Study Group</aucorp><aucorp>For the Sunbelt Melanoma Trial Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complications associated with sentinel lymph node biopsy for melanoma</atitle><jtitle>Annals of surgical oncology</jtitle><addtitle>Ann Surg Oncol</addtitle><date>2003-07-01</date><risdate>2003</risdate><volume>10</volume><issue>6</issue><spage>676</spage><epage>680</epage><pages>676-680</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>Sentinel lymph node (SLN) biopsy has become widely accepted as a method of staging the regional lymph nodes for patients with melanoma. Although it is often stated that SLN biopsy is a minimally invasive procedure associated with few complications, a paucity of data exists to specifically determine the morbidity associated with this procedure. This analysis was performed to evaluate the morbidity associated with SLN biopsy compared with completion lymph node dissection (CLND).
Patients were enrolled in the Sunbelt Melanoma Trial, a prospective multi-institutional study of SLN biopsy for melanoma. Patients underwent SLN biopsy and were prospectively followed up for the development of complications associated with this technique. Patients who had evidence of nodal metastasis in the SLN underwent CLND. Complications associated with SLN biopsy alone were compared with those associated with SLN biopsy plus CLND.
A total of 2120 patients were evaluated, with a median follow-up of 16 months. Overall, 96 (4.6%) of 2120 patients developed major or minor complications associated with SLN biopsy, whereas 103 (23.2%) of 444 patients experienced complications associated with SLN biopsy plus CLND. There were no deaths associated with either procedure.
SLN biopsy alone is associated with significantly less morbidity compared with SLN biopsy plus CLND.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>12839853</pmid><doi>10.1245/ASO.2003.10.001</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1068-9265 |
| ispartof | Annals of surgical oncology, 2003-07, Vol.10 (6), p.676-680 |
| issn | 1068-9265 1534-4681 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73424428 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Adult Aged Female Humans Lymph Node Excision - adverse effects Male Melanoma - pathology Middle Aged Morbidity Postoperative Complications Sentinel Lymph Node Biopsy - adverse effects Skin Neoplasms - pathology |
| title | Complications associated with sentinel lymph node biopsy for melanoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T08%3A26%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complications%20associated%20with%20sentinel%20lymph%20node%20biopsy%20for%20melanoma&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Wrightson,%20William%20R&rft.aucorp=Sunbelt%20Melanoma%20Trial%20Study%20Group&rft.date=2003-07-01&rft.volume=10&rft.issue=6&rft.spage=676&rft.epage=680&rft.pages=676-680&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/ASO.2003.10.001&rft_dat=%3Cproquest_cross%3E931230241%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227360058&rft_id=info:pmid/12839853&rfr_iscdi=true |